摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,3,4,6-tetra-O-benzyl-β-D-galactopyranosyl-(1->1)-4,6-di-O-benzyl-α-D-mannopyranoside | 1333473-91-8

中文名称
——
中文别名
——
英文名称
2,3,4,6-tetra-O-benzyl-β-D-galactopyranosyl-(1->1)-4,6-di-O-benzyl-α-D-mannopyranoside
英文别名
——
2,3,4,6-tetra-O-benzyl-β-D-galactopyranosyl-(1->1)-4,6-di-O-benzyl-α-D-mannopyranoside化学式
CAS
1333473-91-8
化学式
C54H58O11
mdl
——
分子量
883.048
InChiKey
VNPFMEIYGZFTHQ-LJSDRTDSSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.95
  • 重原子数:
    65.0
  • 可旋转键数:
    22.0
  • 环数:
    8.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    123.53
  • 氢给体数:
    2.0
  • 氢受体数:
    11.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2,3,4,6-tetra-O-benzyl-β-D-galactopyranosyl-(1->1)-4,6-di-O-benzyl-α-D-mannopyranoside棕榈酸4-二甲氨基吡啶N,N'-二环己基碳二亚胺 作用下, 以 为溶剂, 以80%的产率得到2,3,4,6-tetra-O-benzyl-β-D-galactopyranosyl-(1->1)-4,6-di-O-benzyl-3-O-palmitoyl-α-D-mannopyranoside
    参考文献:
    名称:
    Synthesis, gp120 binding and anti-HIV activity of fatty acid esters of 1,1-linked disaccharides
    摘要:
    Inspired by the anti-human immunodeficiency virus (HIV) activity of analogues of beta-galactosylceramide (GalCer), a set of mono- and di-saccharide fatty acid esters were designed as GalCer mimetics and their binding to the V3 loop peptide of HIV-1 and anti-HIV activity evaluated. 1,1-linked Gal-Man and Glu-Man disaccharides with an ester on the Man subunit bound the V3 loop peptide and inhibited HIV infectivity in single round infection assays with the TZM-bl cell line. IC50's were in the 50 mu M range with no toxicity to the cells at concentrations up to 200 mu M. These compounds appear to inhibit virus entry at early steps in viral infection since they were inactive if added post viral entry. Although these compounds were found to bind to the V3 loop peptide of gp120, it is not clear that this interaction is responsible for their anti-HIV activity because the relative binding affinity of closely related analogues did not correlate with their antiviral behavior. The low cytotoxicity of these 1,1-linked disaccharide fatty acid esters, combined with the easy accessibility to structurally diverse analogues make these molecules attractive leads for new topical anti-viral agents. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2011.06.078
  • 作为产物:
    描述:
    2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl-(1->1)-2,3:4,6-di-O-isopropylidene-α-D-mannopyranoside 在 sodium methylate四丁基碘化铵 、 sodium hydride 、 对甲苯磺酸 作用下, 以 四氢呋喃甲醇 、 mineral oil 为溶剂, 反应 2.25h, 生成 2,3,4,6-tetra-O-benzyl-β-D-galactopyranosyl-(1->1)-4,6-di-O-benzyl-α-D-mannopyranoside
    参考文献:
    名称:
    Synthesis, gp120 binding and anti-HIV activity of fatty acid esters of 1,1-linked disaccharides
    摘要:
    Inspired by the anti-human immunodeficiency virus (HIV) activity of analogues of beta-galactosylceramide (GalCer), a set of mono- and di-saccharide fatty acid esters were designed as GalCer mimetics and their binding to the V3 loop peptide of HIV-1 and anti-HIV activity evaluated. 1,1-linked Gal-Man and Glu-Man disaccharides with an ester on the Man subunit bound the V3 loop peptide and inhibited HIV infectivity in single round infection assays with the TZM-bl cell line. IC50's were in the 50 mu M range with no toxicity to the cells at concentrations up to 200 mu M. These compounds appear to inhibit virus entry at early steps in viral infection since they were inactive if added post viral entry. Although these compounds were found to bind to the V3 loop peptide of gp120, it is not clear that this interaction is responsible for their anti-HIV activity because the relative binding affinity of closely related analogues did not correlate with their antiviral behavior. The low cytotoxicity of these 1,1-linked disaccharide fatty acid esters, combined with the easy accessibility to structurally diverse analogues make these molecules attractive leads for new topical anti-viral agents. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2011.06.078
点击查看最新优质反应信息